(FINANCIAL TIMES) - It was the fastest vaccine development in history. But now pharmaceutical companies are preparing to do it all over again.
With the emergence of worrying variants that could make Sars-CoV-2 - the virus that causes Covid-19 - more transmissible, more deadly or more resistant to vaccines, the drugmakers that responded in record time are rushing to head off new threats.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
